These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28035683)

  • 1. Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation.
    De Smet F; Saiz Rubio M; Hompes D; Naus E; De Baets G; Langenberg T; Hipp MS; Houben B; Claes F; Charbonneau S; Delgado Blanco J; Plaisance S; Ramkissoon S; Ramkissoon L; Simons C; van den Brandt P; Weijenberg M; Van England M; Lambrechts S; Amant F; D'Hoore A; Ligon KL; Sagaert X; Schymkowitz J; Rousseau F
    J Pathol; 2017 May; 242(1):24-38. PubMed ID: 28035683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity.
    Herzog G; Shmueli MD; Levy L; Engel L; Gazit E; Klärner FG; Schrader T; Bitan G; Segal D
    Biochemistry; 2015 Jun; 54(24):3729-38. PubMed ID: 26030124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerability of newly synthesized proteins to proteostasis stress.
    Xu G; Pattamatta A; Hildago R; Pace MC; Brown H; Borchelt DR
    J Cell Sci; 2016 May; 129(9):1892-901. PubMed ID: 27026526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein aggregation promotes platinum resistance in ovarian cancer.
    Yang-Hartwich Y; Soteras MG; Lin ZP; Holmberg J; Sumi N; Craveiro V; Liang M; Romanoff E; Bingham J; Garofalo F; Alvero A; Mor G
    Oncogene; 2015 Jul; 34(27):3605-16. PubMed ID: 25263447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation.
    Naus E; Derweduwe M; Lampi Y; Claeys A; Pauwels J; Langenberg T; Claes F; Xu J; Haemels V; Atak ZK; van der Kant R; Van Durme J; De Baets G; Ligon KL; Fiers M; Gevaert K; Aerts S; Rousseau F; Schymkowitz J; De Smet F
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.
    Palanikumar L; Karpauskaite L; Al-Sayegh M; Chehade I; Alam M; Hassan S; Maity D; Ali L; Kalmouni M; Hunashal Y; Ahmed J; Houhou T; Karapetyan S; Falls Z; Samudrala R; Pasricha R; Esposito G; Afzal AJ; Hamilton AD; Kumar S; Magzoub M
    Nat Commun; 2021 Jun; 12(1):3962. PubMed ID: 34172723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM4 is a rational target for treating breast cancers with mutant p53.
    Miranda PJ; Buckley D; Raghu D; Pang JB; Takano EA; Vijayakumaran R; Teunisse AF; Posner A; Procter T; Herold MJ; Gamell C; Marine JC; Fox SB; Jochemsen A; Haupt S; Haupt Y
    J Pathol; 2017 Apr; 241(5):661-670. PubMed ID: 28097652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer.
    Yamada H; Shinmura K; Yamamura Y; Kurachi K; Nakamura T; Tsuneyoshi T; Yokota N; Maekawa M; Sugimura H
    Int J Cancer; 2009 Aug; 125(4):973-6. PubMed ID: 19405127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV; Herzog CR; Rao CV
    Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitro.
    Chen Z; Chen J; Keshamouni VG; Kanapathipillai M
    Biochem Biophys Res Commun; 2017 Jul; 489(2):130-134. PubMed ID: 28536076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines.
    Matsumoto H; Shimura M; Omatsu T; Okaichi K; Majima H; Ohnishi T
    Cancer Lett; 1994 Nov; 87(1):39-46. PubMed ID: 7954368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
    Xiong S; Pant V; Zhang Y; Aryal NK; You MJ; Kusewitt D; Lozano G
    J Pathol; 2017 Mar; 241(4):501-510. PubMed ID: 27925213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.